Evaluation of the active constituents of <i>Nilavembu Kudineer</i> for viral replication inhibition against <scp>SARS</scp> ‐ <scp>CoV</scp> ‐2: An approach to targeting <scp>RNA</scp> ‐dependent <scp>RNA</scp> polymerase ( <scp>RdRp</scp> )
Anisha Kuriakose(Amrita Institute of Medical Sciences and Research Centre), Lekshmi R. Nath(Rajiv Gandhi Centre for Biotechnology), Bijo Mathew(Amrita Vishwa Vidyapeetham), Adeniyi T. Adewum(University of KwaZulu-Natal), Mohamed A. Abdelgawad(Jouf University), Mahmoud E. S. Soliman(University of KwaZulu-Natal), Bhagyalakshmi Nair(Amrita Institute of Medical Sciences and Research Centre)
Cited by 9
Related Papers
Metal complexes in cancer therapy &ndash; an update from drug design perspective
|Drug Design Development and Therapy|2017|897
Harnessing the immune system against cancer: current immunotherapy approaches and therapeutic targets
|Molecular Biology Reports|2021|148
Review of the Recent Advances in Electrospun Nanofibers Applications in Water Purification
|Polymers|2022|93
<i>In silico</i> screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2
|Journal of Biomolecular Structure and Dynamics|2021|81
Inevitable role of TGF-β1 in progression of nonalcoholic fatty liver disease
|Journal of Receptors and Signal Transduction|2020|74